The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study.

Publication Type:

Journal Article


Journal of acquired immune deficiency syndromes (1999), Volume 47, Issue 1, p.93-100 (2008)


2008, Administration, Topical, Adult, Africa, Antiviral Agents, Female, HIV Infections, Humans, Incidence, PREGNANCY, Sexual Partners, Vaccine and Infectious Disease Institute


To evaluate the preparedness for phase 2/IIb/III microbicide trials at 4 clinical trial sites: Durban and Hlabisa (South Africa), Lusaka (Zambia), and Moshi (Tanzania).